PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.04%
Revenue growth at 75-90% of MRVL's 1.36%. Bill Ackman would push for innovation or market expansion to catch up.
0.29%
Gross profit growth under 50% of MRVL's 6.45%. Michael Burry would be concerned about a severe competitive disadvantage.
0.32%
EBIT growth below 50% of MRVL's 915.03%. Michael Burry would suspect deeper competitive or cost structure issues.
-0.96%
Negative operating income growth while MRVL is at 915.03%. Joel Greenblatt would press for urgent turnaround measures.
297.09%
Net income growth 1.25-1.5x MRVL's 233.12%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
294.29%
EPS growth 1.25-1.5x MRVL's 231.25%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
297.06%
Diluted EPS growth 1.25-1.5x MRVL's 231.25%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
-0.20%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.20%
Reduced diluted shares while MRVL is at 1.92%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.20%
Maintaining or increasing dividends while MRVL cut them. John Neff might see a strong edge in shareholder returns.
-42.35%
Negative OCF growth while MRVL is at 13.72%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-45.64%
Negative FCF growth while MRVL is at 12.56%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
56.33%
10Y revenue/share CAGR above 1.5x MRVL's 6.34%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
47.90%
Positive 5Y CAGR while MRVL is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
27.80%
Positive 3Y CAGR while MRVL is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
134.19%
10Y OCF/share CAGR at 50-75% of MRVL's 190.88%. Martin Whitman might fear a structural deficiency in operational efficiency.
247.85%
Positive OCF/share growth while MRVL is negative. John Neff might see a comparative advantage in operational cash viability.
94.00%
Positive 3Y OCF/share CAGR while MRVL is negative. John Neff might see a big short-term edge in operational efficiency.
178.55%
Net income/share CAGR at 50-75% of MRVL's 335.33%. Martin Whitman might question if the firm’s product or cost base lags behind.
324.95%
5Y net income/share CAGR above 1.5x MRVL's 29.84%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
121.24%
3Y net income/share CAGR above 1.5x MRVL's 7.46%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
45.75%
10Y equity/share CAGR in line with MRVL's 43.41%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
9.43%
Positive 5Y equity/share CAGR while MRVL is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
9.04%
Positive short-term equity growth while MRVL is negative. John Neff sees a strong advantage in near-term net worth buildup.
520.16%
Dividend/share CAGR of 520.16% while MRVL is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
196.58%
Dividend/share CAGR of 196.58% while MRVL is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
82.35%
Our short-term dividend growth is positive while MRVL cut theirs. John Neff views it as a comparative advantage in shareholder returns.
13.77%
AR growth well above MRVL's 6.49%. Michael Burry fears inflated revenue or higher default risk in the near future.
3.83%
Inventory growth well above MRVL's 4.27%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-0.77%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
3.16%
Positive BV/share change while MRVL is negative. John Neff sees a clear edge over a competitor losing equity.
0.02%
Debt growth of 0.02% while MRVL is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
-0.26%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
5.87%
We expand SG&A while MRVL cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.